Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3420022 | Revue de Pneumologie Clinique | 2008 | 5 Pages |
Abstract
The experimental models of humanized pneumonia treatments show that the period of bacterial eradication is not uniform. If it lasts 48Â hours for pneumonia with sensitive pneumococci, it is longer for pneumococci resistant to amoxicillin or atypical bacteria. Thus, if the clinical trials conducted in adults with non-severe CAP, have shown that the duration of treatment could be reduced, depending on the existence or not of a comorbidity, to a 3 days amoxicillin treatment, to a 5 days telithromycin treatment, to a 5 days of levofloxacin 750Â mg/day treatment or to a 5 days of ceftriaxone 1Â g / day treatment, it is logical to assume that such reductions cannot be extrapolated to severe unqualified PACs with severe or to those caused by resistant bacteria or atypical bacteria.
Related Topics
Health Sciences
Medicine and Dentistry
Infectious Diseases
Authors
Groupe ECRIR Groupe ECRIR,